The United States Securities and Exchange Commission ("SEC") requires the posting of a notice of a private offering by Vascular BioSciences.

The SEC requires that Vascular BioSciences' private offering is accessible only to those who have previously qualified as "accredited investors"or "foreign investors" as such terms are defined in §506 of Regulation D and §902 of Regulation S.

This notice is required to ensure that the presentation of such information by Vascular BioSciences does not involve any form of general solicitation or general advertising within the meaning of Regulation D §502(c) as promulgated under the Securities Act of 1933.

Vascular BioSciences provides the opportunity for prospective investors to qualify as accredited or foreign investors by filling out confidential questionnaires to determine their status.

After qualification, prospective investors may obtain information about private placements available from Vascular BioSciences. Qualification ensures that prospective investors are contacted in a manner in compliance with regulations promulgated by the SEC.

In order to qualify as an investor permitted to review Vascular BioSciences private placement memorandum, you will need to fill out a questionnaire applicable to your status which focuses on either your financial net worth (e.g., accredited investor status), or your residence outside the U.S. and its territories (e.g., a non-U.S. or "foreign" investor).

Upon qualification in one of these two categories, you will receive an e-mail message notifying you of your qualification status and providing you with information regarding Vascular BioSciences' private placement memorandum.

Please choose one of the following categories of investor qualification and complete the information thereunder.

Click the appropriate link:
Accredited Investor
Foreign Investor

Pursuant to the Securities Act of 1933 and regulations promulgated thereunder, a private placement memorandum may only be obtained after a questionnaire has been completed and forwarded to Vascular BioSciences and the party forwarding same has qualified as a registered Vascular BioSciences Investor under the categories set forth above. The matters set forth on this web site are subject to completion or amendments. The information contained on this web site shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities referenced in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. No offer to buy the securities referenced at this web site can be accepted and no part of the purchase price can be received until a registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date. Indication of interest in response to this web site will involve no obligation or commitment of any kind.